Lemairamin, isolated from the Zanthoxylum plants, alleviates pain hypersensitivity via spinal α7 nicotinic acetylcholine receptors

• Published in: Biochemical and biophysical research communications 2020-05, Vol.525 (4), p.1087-1094
• Main Authors: Wang, Zi-Ying, Han, Qiao-Qiao, Deng, Meng-Yan, Zhao, Meng-Jing, Apryani, Evhy, Shoaib, Rana Muhammad, Wei, Dong-Qing, Wang, Yong-Xiang
• Format: Article
• Language: English
• Subjects: Aconitine - analogs & derivatives; Aconitine - pharmacology; Acrylamides - administration & dosage; Acrylamides - pharmacology; Acrylamides - therapeutic use; alpha7 Nicotinic Acetylcholine Receptor - agonists; alpha7 Nicotinic Acetylcholine Receptor - genetics; alpha7 Nicotinic Acetylcholine Receptor - metabolism; Analgesics - administration & dosage; Analgesics - pharmacology; Analgesics - therapeutic use; Animals; beta-Endorphin - genetics; beta-Endorphin - metabolism; Cancer Pain - drug therapy; Female; Formaldehyde; Hyperalgesia - drug therapy; Hyperalgesia - genetics; Hyperalgesia - metabolism; IL-10; Injections, Spinal; Interleukin-10 - genetics; Interleukin-10 - metabolism; Lemairamin (wgx-50); Male; Mice; Microglia - drug effects; Microglia - metabolism; Minocycline - administration & dosage; Naloxone - administration & dosage; Neuralgia - drug therapy; Pain hypersensitivity; Rats; Rats, Wistar; Spinal Cord - metabolism; Zanthoxylum - chemistry; Zanthoxylum - metabolism; α7 nicotinic acetylcholine receptor (α7nAChR); β-endorphin
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2020.03.023

Lemairamin (also known as wgx-50), is isolated from the pericarps of the Zanthoxylum plants. As an agonist of α7 nicotinic acetylcholine receptors (α7nAChRs), it can reduce neuroinflammation in Alzheimer’s disease. This study evaluated its antinociceptive effects in pain hypersensitivity and explored the underlying mechanisms. The data showed that subcutaneous lemairamin injection dose-dependently inhibited formalin-induced tonic pain but not acute nociception in mice and rats, while intrathecal lemairamin injection also dose-dependently produced mechanical antiallodynia in the ipsilateral hindpaws of neuropathic and bone cancer pain rats without affecting mechanical thresholds in the contralateral hindpaws. Multiple bi-daily lemairamin injections for 7 days did not induce mechanical antiallodynic tolerance in neuropathic rats. Moreover, the antinociceptive effects of lemairamin in formalin-induced tonic pain and mechanical antiallodynia in neuropathic pain were suppressed by the α7nAChR antagonist methyllycaconitine. In an α7nAChR antagonist-reversible manner, intrathecal lemairamin also stimulated spinal expression of IL-10 and β-endorphin, while lemairamin treatment induced IL-10 and β-endorphin expression in primary spinal microglial cells. In addition, intrathecal injection of a microglial activation inhibitor minocycline, anti-IL-10 antibody, anti-β-endorphin antiserum or μ-opioid receptor-preferred antagonist naloxone was all able to block lemairamin-induced mechanical antiallodynia in neuropathic pain. These data demonstrated that lemairamin could produce antinociception in pain hypersensitivity through the spinal IL-10/β-endorphin pathway following α7nAChR activation. •Lemairamin produces antinociception in rodent models of pain hypersensitivity.•Lemairamin alleviates pain hypersensitivity through activation of spinal α7nAChR.•Spinal IL-10/β-endorphin pathway mediates α7nAChR agonism-induced antinociception.